| Medical Policy |
Revision |
| Cardiovascular Disease Risk Assessment AHS – G2050 "Notification" |
Off-cycle review by Avalon 2nd Quarter 2022 CAB. Description, Related Policies, Policy Guidelines, and References updated. Coverage criteria updated to remove criteria related to genetic markers for cardiovascular disease as this has been moved to new policy Genetic Markers for Assessing Risk of Cardiovascular Disease AHS M2180. Billing/Coding section updated. Medical Director review 7/2022. Notification given on 9/13/22 for effective date 10/18/22. |
| Genetic Markers for Assessing Risk of Cardiovascular Disease AHS M2180 "Notification" |
New policy developed. Genetic Markers for Assessing Risk of Cardiovascular Disease is considered investigational for [all applications}. BCBSNC does not provide coverage for investigational services or procedures. Medical Director review 7/2022. Notification given 9/13/2022 for effective date 10/18/2022. |
| Prenatal Screening (Nongenetic) AHS – G2035 "Notification" |
Reviewed by Avalon 2nd quarter 2022 CAB. Policy re-titled: Prenatal Screening (Nongenetic). Description, Related Policies, Policy Guidelines, and References updated. Coverage criteria updated to remove criteria related to genetic prenatal screening as this has been moved to new policy – Prenatal Screening (genetic). Billing/Coding section updated. Medical Director review 7/2022. Notification given on 9/13/2022 for effective date 10/18/2022. |
| Prenatal Screening (Genetic) AHS-M2179 "Notification" |
New policy developed. BCBSNC will provide coverage for Prenatal Screening (genetic) when the medical criteria and guidelines outlined in the policy are met. Medical Director review 7/2022. Notification give 9/13/2022 for effective date 10/18/2022. |
Blue Connect